---
layout: minimal-medicine
title: Cladribine
---

# Cladribine
### Generic Name
Cladribine

### Usage

Cladribine is primarily used to treat hairy cell leukemia, a rare type of blood cancer.  It's administered intravenously (IV) for this indication.  Importantly, cladribine also has an approved use in treating relapsing forms of multiple sclerosis (MS), specifically relapsing-remitting (RRMS) and active secondary progressive MS, in adults who haven't responded well to or can't tolerate other MS treatments.  For MS, it's given orally.  It's crucial to understand that while cladribine has shown some promise in other cancers like acute myeloid leukemia (AML) and mantle cell lymphoma, these uses are considered off-label, meaning they are not officially approved by regulatory agencies.  A physician will only prescribe it for these conditions after careful consideration of the risks and benefits.


### Dosage

Cladribine dosage varies significantly depending on the condition being treated and the route of administration (IV or oral).  Precise instructions are crucial and must be followed exactly as directed by a healthcare professional.  This information is for general knowledge only and should not be used to self-medicate.

**Hairy Cell Leukemia (IV):**  Dosage regimens vary, typically involving a daily IV infusion over several days for one or more cycles.  The specific dose (mg/kg/day) and duration will be determined by the physician based on factors such as the patient's overall health and the severity of the disease.  Subcutaneous (under the skin) administration may also be used off-label, with similar dosage considerations.

**Multiple Sclerosis (Oral):**  The approved oral dosage for MS is a total of 3.5 mg/kg given over two years, divided into two 1.75 mg/kg yearly courses.  Each yearly course further splits into two cycles, administered over 4-5 consecutive days with a significant break between cycles (at least 23-27 days).  There is a significant time interval between the end of the first year's treatment and the beginning of the second year's treatment. This schedule is critical for safety and efficacy.  The daily dose should not exceed 20 mg.  Lymphocyte counts must be monitored closely before and during treatment.

**Pediatric and other off-label uses:**  Dosage for children with AML or other conditions where cladribine is used off-label will be carefully determined by a specialist based on weight (mg/mÂ²) and overall health.  These dosages are significantly different than those for adults and must be precisely followed.


### Side Effects

Cladribine can cause various side effects, ranging from mild to severe.  The severity and frequency of side effects can vary depending on the dosage and the individual's overall health.

**Common Side Effects:**

* Fatigue
* Headache
* Nausea
* Decreased appetite
* Vomiting
* Neutropenia (low white blood cell count)
* Anemia (low red blood cell count)
* Thrombocytopenia (low platelet count)
* Skin rash
* Infections


**Serious but Less Common Side Effects:**

* Aplastic anemia (severe bone marrow failure)
* Progressive multifocal leukoencephalopathy (PML; a rare brain infection)
* Severe allergic reactions
* Renal (kidney) failure
* Hepatotoxicity (liver damage)
* Neurotoxicity (nerve damage)


**Important Note:**  This is not an exhaustive list. If you experience any unexpected or concerning side effects, immediately contact your healthcare provider.


### How it Works

Cladribine is a type of chemotherapy drug called a purine nucleoside analogue.  It works by interfering with the production and function of DNA within rapidly dividing cells, such as cancer cells or certain immune cells involved in MS.  Once activated inside the cells, cladribine gets incorporated into DNA, causing DNA strand breaks and inhibiting DNA repair and synthesis, ultimately leading to cell death.


### Precautions

Several precautions are essential when using cladribine:

* **Contraindications:**  Cladribine is contraindicated in patients with hypersensitivity to the drug and various situations depending on the form of administration (oral or IV).  For the oral form, additional contraindications include current malignancy, pregnancy, breastfeeding, HIV infection, active chronic infections, and moderate to severe renal impairment.  
* **Drug Interactions:** Cladribine can interact with other medications, potentially affecting their effectiveness or increasing the risk of side effects. Inform your physician about all medications you are taking, including over-the-counter drugs, supplements, and herbal remedies.
* **Specific Populations:**  Pregnant and breastfeeding women should not use cladribine.  The use of contraception is mandatory.  Patients with impaired kidney or liver function require careful monitoring and dose adjustments, which should always be done under a doctor's supervision.
* **Monitoring:** Regular blood tests are necessary to monitor blood cell counts and kidney and liver function, especially during and after treatment.


### FAQs

* **Q: How should I store cladribine?** A: Follow the specific storage instructions provided with your prescription.  Generally, medications should be kept in a cool, dry place, away from direct sunlight and moisture.

* **Q: Can I drink alcohol while taking cladribine?** A: It's best to avoid alcohol while on cladribine, as it can worsen some side effects, such as nausea and fatigue.  Always consult your doctor.

* **Q: What should I do if I miss a dose?** A: Do not attempt to adjust your dosage regimen on your own. Immediately contact your healthcare professional to determine the appropriate course of action.

* **Q:  How long will I need to take cladribine?** A: The duration of treatment varies considerably depending on the disease and the treatment response. Your healthcare provider will determine the appropriate treatment duration.

* **Q: Are there any long-term effects of cladribine?** A: Long-term effects are possible, and regular monitoring is crucial.  Your doctor will discuss potential long-term risks and benefits with you.


**Disclaimer:**  This information is for general educational purposes only and should not be considered medical advice. Always consult with a healthcare professional before starting or stopping any medication, including cladribine.  They can provide personalized recommendations based on your specific health status and medical history.
